{
  "metadata": {
    "case_id": 60,
    "model": "GPT-5.1",
    "timestamp": "2025-11-29T17:41:00.382149",
    "total_alignments": 5,
    "target_section": "protocolSection",
    "ground_truth_path": "/{YOURPATH}/samples/CTG/protocolSection/1_100/60_NCT04124536.json",
    "prediction_path": "/{YOURPATH}/restructured_outputs_protocol/GPT-5.1/60_GPT-5.1.json",
    "shard_range": "1_100"
  },
  "alignments": [
    {
      "field_path": "protocolSection.identificationModule.secondaryIdInfos",
      "algorithm": "hungarian",
      "ref_count": 1,
      "pred_count": 7,
      "similarity_matrix": [
        [
          0.95,
          0.82,
          0.86,
          0.78,
          0.9,
          0.7,
          0.7
        ]
      ],
      "matched_pairs": [
        {
          "ref_idx": 0,
          "pred_idx": 0,
          "score": 0.95,
          "status": "matched",
          "ref_item": {
            "id": "R01AI131060",
            "type": "NIH",
            "link": "https://reporter.nih.gov/quickSearch/R01AI131060"
          },
          "pred_item": {
            "id": "R01 AI131060",
            "type": "NIH",
            "domain": "National Institute of Allergy and Infectious Diseases",
            "link": null
          }
        }
      ]
    },
    {
      "field_path": "protocolSection.armsInterventionsModule.armGroups",
      "algorithm": "hungarian",
      "ref_count": 2,
      "pred_count": 4,
      "similarity_matrix": [
        [
          0.4,
          0.84,
          0.72,
          0.86
        ],
        [
          0.78,
          0.18,
          0.7,
          0.25
        ]
      ],
      "matched_pairs": [
        {
          "ref_idx": 0,
          "pred_idx": 3,
          "score": 0.86,
          "status": "matched",
          "ref_item": {
            "label": "Intervention",
            "type": "EXPERIMENTAL",
            "description": "In addition to standard partner notification services, the intervention arm will receive HIV self-test kits and structured counseling about HIVST, regardless of HIV status.",
            "interventionNames": [
              "Behavioral: HIV self-testing with partner notification."
            ]
          },
          "pred_item": {
            "label": "Trial 2 Intervention: Partner Notification plus HIV Self-testing",
            "type": "EXPERIMENTAL",
            "description": "HIV-negative pregnant women received adapted assisted partner notification services plus a combination strategy that included targeted education on oral HIV self-testing and secondary distribution of up to five OraQuick oral HIV self-test kits for use by their primary male partners (and by the women themselves if desired). Women were counselled to encourage facility-based HIV testing and confirmatory testing at a health facility regardless of self-test result.",
            "interventionNames": [
              "Partner notification services (HIV-negative women)",
              "Secondary distribution of oral HIV self-test kits with education"
            ]
          }
        },
        {
          "ref_idx": 1,
          "pred_idx": 0,
          "score": 0.78,
          "status": "matched",
          "ref_item": {
            "label": "Control",
            "type": "NO_INTERVENTION",
            "description": "Standard partner notification services, regardless of HIV status."
          },
          "pred_item": {
            "label": "Trial 1 Control: Partner Notification Only",
            "type": "ACTIVE_COMPARATOR",
            "description": "HIV-positive pregnant women received standard assisted partner notification services only. Women selected one of four WHO-recommended partner notification options (client self-referral, provider contract referral, provider referral, or dual referral) to facilitate HIV testing of their primary male partner at a health facility or through other routine services. No HIV self-test kits were provided.",
            "interventionNames": [
              "Partner notification services (HIV-positive women)"
            ]
          }
        }
      ]
    },
    {
      "field_path": "protocolSection.armsInterventionsModule.interventions",
      "algorithm": "hungarian",
      "ref_count": 1,
      "pred_count": 3,
      "similarity_matrix": [
        [
          0.82,
          0.84,
          0.9
        ]
      ],
      "matched_pairs": [
        {
          "ref_idx": 0,
          "pred_idx": 2,
          "score": 0.9,
          "status": "matched",
          "ref_item": {
            "type": "BEHAVIORAL",
            "name": "HIV self-testing with partner notification.",
            "description": "HIV self-test kits are oral swabs. Partner notification will be offered to all women in the intervention arm, regardless of HIV status.",
            "armGroupLabels": [
              "Intervention"
            ]
          },
          "pred_item": {
            "type": "DIAGNOSTIC_TEST",
            "name": "Secondary distribution of oral HIV self-test kits with education",
            "description": "Targeted education and instruction on how to use oral HIV self-test kits (OraQuick) plus provision of up to five oral HIV self-test kits for each enrolled woman to give to her primary male partner (and for self-use if desired). Written multilingual instructions (English, Bemba, Nyanja) approved by the Zambia Ministry of Health were provided. Women were counselled that HIV testing by a health-care provider at a facility was recommended for all, including confirmatory testing at a health facility after any self-test regardless of result, to facilitate linkage to prevention and treatment services.",
            "armGroupLabels": [
              "Trial 1 Intervention: Partner Notification plus HIV Self-testing",
              "Trial 2 Intervention: Partner Notification plus HIV Self-testing"
            ]
          }
        }
      ]
    },
    {
      "field_path": "protocolSection.outcomesModule.primaryOutcomes",
      "algorithm": "hungarian",
      "ref_count": 1,
      "pred_count": 1,
      "similarity_matrix": [
        [
          0.95
        ]
      ],
      "matched_pairs": [
        {
          "ref_idx": 0,
          "pred_idx": 0,
          "score": 0.95,
          "status": "matched",
          "ref_item": {
            "measure": "Number of Participants Who Reported Primary Male Partner Completed HIV Testing at a Healthcare Facility",
            "description": "The number of participants who report their primary male partners getting tested for HIV at a healthcare facility when presented with partner notification plus secondary distribution of HIV self-test kits compared to partner notification alone",
            "timeFrame": "Enrollment - 30 days post enrollment of study participant"
          },
          "pred_item": {
            "measure": "Facility-based male partner HIV testing within 30 days",
            "description": "Proportion of primary male partners reported by enrolled pregnant women to have tested for HIV at a health facility (by trained health-care personnel) within 30 days following randomisation, using a complete-case approach.",
            "timeFrame": "Within 30 days after randomisation"
          }
        }
      ]
    },
    {
      "field_path": "protocolSection.outcomesModule.otherOutcomes",
      "algorithm": "hungarian",
      "ref_count": 1,
      "pred_count": 6,
      "similarity_matrix": [
        [
          0.94,
          0.74,
          0.18,
          0.22,
          0.08,
          0.68
        ]
      ],
      "matched_pairs": [
        {
          "ref_idx": 0,
          "pred_idx": 0,
          "score": 0.94,
          "status": "matched",
          "ref_item": {
            "measure": "Number of Participants Who Reported Primary Male Partner HIV Testing Completed at Any Venue",
            "description": "The number of participants who report their primary male partners getting tested for HIV at any venue when presented with partner notification plus secondary distribution of HIV self-test kits (SD-HIVST) compared to partner notification alone",
            "timeFrame": "Enrollment - 30 days post enrollment of study participant"
          },
          "pred_item": {
            "measure": "Male partner HIV testing of any kind within 30 days",
            "description": "Proportion of primary male partners reported by enrolled pregnant women to have undergone HIV testing of any kind (including facility-based testing, HIV self-testing in the household, or testing in other community-based venues) within 30 days of randomisation.",
            "timeFrame": "Within 30 days after randomisation"
          }
        }
      ]
    }
  ]
}